Ovarian Stimulation Current Events | Ovarian Stimulation News | 5
|
| Page
5 of
20 |
381 Results |
|
|
|
Sort By:
Page Views | Date |
Study fuels debate over whether exercise and body size influence ovarian cancer risk
A new study adds fuel to the debate over whether being fat or inactive affects the risk of developing ovarian cancer. view more (2007-09-27)
Nursing study concludes few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes
An Ontario study of 491 women with invasive ovarian cancer found only a small proportion, 19%, were referred for genetic testing of BRCA1 and BRCA2, the breast cancer genes, which means family members are not informed of their cancer risk. view more (2008-12-05)
Genetic variations in miRNA processing pathway and binding sites help predict ovarian cancer risk
Genetic variations in the micro-RNA (miRNA) processing pathway genes and miRNA binding sites predict a woman's risk for developing ovarian cancer and her prospects for survival. view more (2009-04-20)
Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers
The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center. view more (2009-04-20)
'Clumping' protein linked to return of ovarian cancer
Johns Hopkins scientists have discovered that women treated for ovarian cancer are at increased risk of a rapid and potentially fatal recurrence if their tumor cells have high levels of a binding protein that triggers abnormal growth and slows down cell death, both hallmarks of malignancy. view more (2006-12-18)
New form of ECT is as effective as older types but without cognitive side effects
In a study appearing in the new issue of BRAIN STIMULATION, scientists report that a new form of electroconvulsive therapy (ECT) is just as effective as older forms in treating depression but without any of the cognitive side effects found in the older forms. view more (2008-05-27)
Obesity leads to more aggressive ovarian cancer, Cedars-Sinai research shows
Whether or not a woman is obese will likely affect her outcome once she has been diagnosed with ovarian cancer, according to a new study from Cedars-Sinai Medical Center. view more (2006-08-28)
Removal of ovaries decreases risk of certain cancers for women at high-risk
Women with mutations in the BRCA1 or BRCA2 genes can significantly reduce their risk of certain types of cancer by having their ovaries removed. view more (2006-07-12)
International Study Suggests Carboplatin Could Be First-line Chemotherapy Drug For Ovarian Cancer
Results of an international study in this week's issue of THE LANCET suggest that the drug carboplatin could become a first-line chemotherapeutic agent for the treatment of ovarian cancer. Carboplatin was found to be less toxic, although it had no overall survival benefit, compared with other drugs assessed in the study. Ovarian cancer is the... view more... (2002-08-14)
New therapy gives hope for very severe depression
Thanks to a new method there is a reason for hope for patients with very severe depression. Physicians at the University Clinics of Bonn and Cologne have treated ten patients with deep brain stimulation. view more (2009-11-03)
Angiogenesis linked to poor survival in patients with rare type of ovarian cancer
Researchers from The University of Texas M. D. Anderson Cancer Center have found that increased angiogenesis, or blood vessel formation, and vascular endothelial growth factor expression are associated with poor survival in women with sex cord-stromal ovarian tumors. view more (2009-02-06)
Discovery of follicles offers hope of babies for Turner's syndrome girls
Lausanne, Switzerland: Swedish researchers have found that teenage girls with Turner's syndrome still have follicles in their ovaries which may be capable of producing eggs. This discovery offers hope that Turner's syndrome girls may be able to have babies in the future. Mr Julius Hreinsson, an embryologist in the Fertility Unit at Huddinge... view more... (2001-07-03)
Mayo Clinic reports possible new therapy for patients with platinum-resistant ovarian cancer
Mayo Clinic today reported promising interim results from a Phase II trial of a new combination therapy for patients with recurrent ovarian cancer that is resistant to platinum therapy. Thirty-three percent of study participants achieved either complete or partial tumor regression from the therapy, which combines flavopiridol and cisplatin. view more (2007-10-24)
Controversies Regarding Ovarian Cancer Treatments Addressed
Trials have raised questions on the current management and standard of care for advanced ovarian cancer (AOC). These controversies highlight implications for future clinical research and policy-making, as reviewed in an article published in the International Journal of Gynecological Cancer. view more (2004-11-10)
Study provides clues to prevent spread of ovarian cancer
A drug that blocks production of an enzyme that enables ovarian cancer to gain a foothold in a new site can slow the spread of the disease and prolong survival in mice, according to a study by researchers from the University of Chicago Medical Center, but only if the drug is given early in the disease process. view more (2008-03-14)
Radical surgery best option for most ovarian cancer patients with cancer in diaphragm
In a retrospective study looking back at a decade of surgeries, Mayo Clinic Cancer Center researchers have determined that surgery to remove metastatic disease from the diaphragm, in conjunction with other procedures to remove the primary diseased tissue in ovarian cancer patients, significantly increases survival rates. view more (2005-10-13)
Intraperitoneal chemotherapy administration prolongs survival for women with advanced ovarian cancer
A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy. view more (2006-01-05)
Genetic testing for breast or ovarian cancer risk may be greatly underutilized
Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds that few women with family histories of these cancers are even discussing genetic testing with their physicians or other health care providers. view more (2009-05-22)
Experimental Drug Boosts Survival in Recurrent Ovarian Cancer Patients
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently. view more (2007-09-28)
Newly discovered gene may predict aggressive ovarian cancer
Johns Hopkins Kimmel Cancer Center researchers have linked alterations in a gene, called Rsf-1, to the most deadly ovarian cancers. view more (2005-09-30)
|
|
| Page
5 of
20 |
381 Results |
|
|
|
Sort By:
Page Views | Date |
|
